Endogenous epinephrine protects against obesity induced insulin resistance
- 5 July 2011
- journal article
- Published by Elsevier BV in Autonomic Neuroscience
- Vol. 162 (1-2), 32-34
- https://doi.org/10.1016/j.autneu.2011.01.009
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Epinephrine Is Required for Normal Cardiovascular Responses to Stress in the Phenylethanolamine N-Methyltransferase Knockout MouseCirculation, 2007
- Improved insulin‐stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylationActa Physiologica Scandinavica, 2005
- Brown Adipose Tissue: Function and Physiological SignificancePhysiological Reviews, 2004
- Hypoglycemia in DiabetesDiabetes Care, 2003
- Attenuation of insulin resistance by chronic β2-adrenergic agonist treatment Possible muscle specific contributionsLife Sciences, 2001
- Hypothesis:β-Adrenergic Receptor Blockers and Weight GainHypertension, 2001
- Human ageing and the sympathoadrenal systemJournal Of Physiology-London, 2000
- Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivityJournal of Hypertension, 1996
- Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels.JCI Insight, 1995
- A more sensitive and specific radioenzymatic assay for catecholaminesLife Sciences, 1990